Devlin Macgregor is firmly committed to fairness and transparency in our efforts to maximize the financial success of our organization, while preserving the investment integrity for our financial stakeholders
Corporate Name: Devlin Macgregor Pharmaceuticals
Ticker Symbol: FUGTV – Pan American Stock Exchange
Status: Trading Suspended, ruling A55-1993
Price-High: $423.43 (April 1, 1995)
Price-Low: $0.32 (May 21, 2020)
Average Daily Volume: 3,234,204
Beta Risk for Total Loss: Extreme
The trading of common and preferred equity stock of Devlin Macgregor (Symbol: FUGTV) has been has been indefinitely halted as part of an investigation by the Financial Crimes Adjudication Agency. Devlin Macgregor is diligently working with the FCAA to regain compliance so our all of our share classes and option warrants may be re-listed on the Pan-American Stock Exchange (PASE). Existing shareholders should contact the custodian of their brokerage if they are interested in exchanging common shares for restricted warrants. Warrants carry a face value of $0.00001 per unit
Custodial accounts of common equity stockholders under PASE rule 19-93 are managed by the law firm Schitz & Gigills, PC, LP of Chicago, Illinois. The enforcement agreement notice (EAN) covers the corporate strawman covenant of the Uniform Commerce Code (UCC) sections 120, 188, and 223. Information on this webpage page should not, and must not, be considered to be financial or legal advice.
Devlin Macgregor Announces Exploratory Committee for the formation or acquisition of SPAC
December 30, 2020 - For Immediate Release
Devlin Macgregor is pleased to announce the formation of a special corporate committee to investigate the formation, or possibly the acquisition of a Special Purpose Acquisition Company (SPAC) . This financial vehicle will enable Devlin Macgregor an alternative to traditional equity allocation and stock offerings. The committee expects to publish formal guidelines on the SPAC offering in the upcoming quarter.
Andy Shane, Vice President of Financial Obfuscation for Devlin Macgregor was quoted in the WSJ last week,
“I am extremely excited for the prospects of a ‘blank check’ type investment product that we can offer to our stakeholders. The goal of this new SPAC will be to eliminate the nonsense associated with IPO’s and the hundreds of thousands of dollars wasted on time consuming compliance efforts. With SPAC investment products as hot as they are today, Devlin Macgregor must strike while the iron is hot, and empower our legacy and future investors the opportunity to cash-in on this mania”